12,13-diHOME Is Increased During Targeted Temperature Management And Correlates With Survival After Cardiac Arrest Resuscitation
CONTEXT: Trials of targeted temperature management (TTM) after cardiac arrest (CA) have had conflicting results. Brown adipose tissue (BAT) is a thermogenic organ activated by cold temperature to regulate body temperature, systemic metabolism and the immune system. Approximately 10-30% of adult patients have BAT and this heterogeneity may explain variable treatment to TTM. OBJECTIVE: This study sought to measure differences in outcome, metabolic and immune activation between patients treated with TTM following CA with varying BAT activity, measured through BAT-associated lipid 12,13-diHOME concentrations in circulation. DESIGN: BAT biomarker 12,13-diHOME was quantified using liquid chromatography-mass spectrometry (LC-MS) on plasma from 74 patients at various time points starting at 6 hours and up until 7 days after return of spontaneous circulation (ROSC). Additionally, circulating glucose, C-peptide and fatty acids were measured by glucometer, ELISA and LC-MS, respectively. Peripheral blood mononuclear cells were analyzed by flow cytometry. RESULTS: 12,13-diHOME was increased in patients treated with TTM at 33°C and positively correlated with favorable outcomes. 12,13-diHOME levels peaked in the first 12 to 48 hours and decreased below the first post-ROSC level by 7 days. Glucose homeostasis was not associated with 12,13-diHOME levels. In a subset of patients, we could detect a specific phospholipid signature in patients with higher 12,13-diHOME. Patients with higher 12,13-diHOME also had increased mature neutrophils and lower immature neutrophils. CONCLUSIONS: Circulating 12,13-diHOME levels are increased in some patients undergoing targeted temperature management after cardiac arrest, which may be indicative of increased BAT activity. 12,13-diHOME is associated with survival, alterations of phospholipid metabolism, and a profile of less activated immune system. BAT may mediate the effects of temperature management on outcome after cardiac arrest.
Authors
- Richard R. Riker (ORCID: https://orcid.org/0000-0002-0682-6204)
- Sergey V. Ryzhov (ORCID: https://orcid.org/0000-0002-7930-9814)
- DAVID R. GAGNON (ORCID: https://orcid.org/0000-0002-6367-3179)
- Matthew D. Lynes (ORCID: https://orcid.org/0000-0003-0746-0854)
- Joanne T. deKay (ORCID: https://orcid.org/0000-0001-7916-6641)
- Teresa May (ORCID: https://orcid.org/0000-0002-9130-8013)
- Ryan Reno
- Margaret Mahoney (ORCID: https://orcid.org/0000-0003-2845-3792)
- Juan J. Aristizabal‐Henao (ORCID: https://orcid.org/0000-0002-2085-2396)
- David B. Seder (ORCID: https://orcid.org/0000-0002-9717-1038)
- Carolina Cora (ORCID: https://orcid.org/0000-0002-7877-0297)
- Mary Weatherbee
- Patience Mudjgiwa
- Vlada Chekirka
- Michael A Kiebish
- Rika Goto
- James Reilly
- Breanna Page
Institutions
- Tufts University (US)
- Maine Medical Center (US)
- MaineHealth (US)
- Maine Medical Center (US)
- BG Medicine (United States) (US)
- University of Maine (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2026-10-15
- DOI
- https://doi.org/10.1210/clinem/dgag415
- Primary Topic
- Cardiac Arrest and Resuscitation
- Type
- article
- Field-Weighted Citation Impact
- 0.00